| HCVTX | OCGCX | HCVTX / OCGCX | |
| Total Expense Ratio | 0.75 | 1.44 | 52% |
| Annual Report Gross Expense Ratio | 0.75 | 1.44 | 52% |
| Fund Existence | 19 years | 29 years | - |
| Gain YTD | 11.844 | 8.846 | 134% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 145M | 4.35B | 3% |
| Annual Yield % from dividends | 2.48 | 2.74 | 91% |
| Returns for 1 year | 11.11 | 8.29 | 134% |
| Returns for 3 years | 33.08 | 23.95 | 138% |
| Returns for 5 years | 17.82 | 9.15 | 195% |
| Returns for 10 years | 59.36 | 28.21 | 210% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRWBX | 26.07 | 0.01 | +0.04% |
| MFS Blended Research Growth Eq B | |||
| FSIDX | 18.72 | N/A | N/A |
| Fidelity Advisor Strategic Div & Inc I | |||
| FWOEX | 19.50 | N/A | N/A |
| Fidelity Advisor Women's Leadership M | |||
| AEPIX | 28.28 | N/A | N/A |
| Allspring Managed Acct Corebuilder EPI | |||
| TAAHX | 36.22 | -0.01 | -0.03% |
| Transamerica Multi-Managed Balanced R | |||